| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
59,190 |
49,116 |
$3.74M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,478 |
6,385 |
$715K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,236 |
4,160 |
$444K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,524 |
4,463 |
$388K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
14,960 |
13,402 |
$223K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,271 |
2,253 |
$206K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
35,117 |
16,986 |
$177K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,804 |
9,632 |
$104K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27,634 |
24,345 |
$101K |
| 94010 |
|
12,711 |
11,335 |
$92K |
| 92567 |
|
15,649 |
13,726 |
$63K |
| 90670 |
|
3,260 |
3,199 |
$48K |
| 99188 |
|
5,532 |
5,455 |
$33K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
177 |
171 |
$14K |
| 99381 |
|
122 |
112 |
$10K |
| 94664 |
|
7,208 |
6,186 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
295 |
280 |
$5K |
| 83655 |
|
1,330 |
1,307 |
$4K |
| 90651 |
|
661 |
652 |
$3K |
| 87807 |
|
527 |
491 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
334 |
254 |
$2K |
| 90715 |
|
301 |
296 |
$2K |
| 90716 |
|
1,833 |
1,801 |
$2K |
| 90686 |
|
867 |
843 |
$1K |
| 90633 |
|
1,702 |
1,658 |
$1K |
| 81002 |
|
1,286 |
1,212 |
$920.79 |
| 85018 |
|
1,419 |
1,403 |
$819.84 |
| 90723 |
|
2,603 |
2,560 |
$619.28 |
| 90707 |
|
1,824 |
1,794 |
$309.88 |
| 90647 |
|
696 |
679 |
$265.91 |
| 90700 |
|
1,904 |
1,864 |
$212.14 |
| 90681 |
|
973 |
949 |
$125.00 |
| 81025 |
|
79 |
76 |
$111.03 |
| 90734 |
|
237 |
235 |
$98.76 |
| 90713 |
|
499 |
490 |
$36.89 |
| 90648 |
|
2,910 |
2,861 |
$0.00 |
| 90677 |
|
226 |
223 |
$0.00 |
| 90620 |
|
28 |
27 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14 |
14 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
26 |
26 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
43 |
28 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
26 |
$0.00 |